These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 16843110)

  • 21. Variant translocation t(2;21;8)(q36;q22;q22) with RUNX1/CBFA2T1 (AML1/ETO) transcript in a case of acute myelogenous leukemia.
    Hsiao HH; Sashida G; Kodama A; Fukutake K; Ohyashiki K
    Cancer Genet Cytogenet; 2005 May; 159(1):96-7. PubMed ID: 15860366
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic significance of the AML1-ETO fusion transcript expression in children and young adults with t(8;21) acute myeloid leukemia.
    Fleischman EW; Baturina JA; Sokova OI; Popa AV; Kosorukova IS; Rowley JD
    Haematologica; 2003 Sep; 88(9):1078-9. PubMed ID: 12969821
    [No Abstract]   [Full Text] [Related]  

  • 23. Complex chromosome 8;21 translocation with associated hyperdiploidy in acute myeloid leukemia (FAB-M2).
    Corral Mdel P; Villa O; Alfaro EM; Alonso CN; Baro C; Felice MS; Rossi J; Solé F; Gallego MS
    Pediatr Blood Cancer; 2008 Mar; 50(3):651-4. PubMed ID: 17405156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute myeloid leukemia (AML-M2) associated with variant t(8;21): report of three cases.
    Bae SY; Kim JS; Ryeu BJ; Lee KN; Lee CK; Kim YK; Lim CS; Cho Y; Choi CW; Ryu SW; Yoon SY
    Cancer Genet Cytogenet; 2010 May; 199(1):31-7. PubMed ID: 20417866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphological and cytogenetic changes in therapy-related leukemia developed in a t(8;21)-acute myeloid leukemia (M2) patient: sequential cytogenetic and molecular analyses.
    Nawata R; Shinohara K; Yamada T; Takahashi T; Katsuki K; Takeda K; Kameda N; Ariyoshi K; Ota I; Muraki K
    Int J Hematol; 2000 Jun; 71(4):353-8. PubMed ID: 10905055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.
    Krauter J; Gorlich K; Ottmann O; Lubbert M; Dohner H; Heit W; Kanz L; Ganser A; Heil G
    J Clin Oncol; 2003 Dec; 21(23):4413-22. PubMed ID: 14645432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
    Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. t(8;21)(q22;q22) Translocation involving AML1 and ETO in B lymphoblastic leukemia [corrected].
    Wang HY; Tirado CA
    Hum Pathol; 2010 Feb; 41(2):286-92. PubMed ID: 19896694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of apoptosis in myeloid leukaemic cells by ribozymes targeted against AML1/MTG8.
    Matsushita H; Kizaki M; Kobayashi H; Muto A; Ikeda Y
    Br J Cancer; 1999 Mar; 79(9-10):1325-31. PubMed ID: 10188872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complex t(8;14;21)(q22;q13;q22), a variant of t(8;21), with t(15;21)(q15;p11) in a patient with acute myelogenous leukemia (M1).
    Takahashi T; Maruyama Y; Satoh Y; Yoshimoto M; Tsujisaki M
    Cancer Genet Cytogenet; 2004 Dec; 155(2):152-3. PubMed ID: 15571802
    [No Abstract]   [Full Text] [Related]  

  • 31. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
    Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
    Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1.
    Storlazzi CT; Anelli L; Albano F; Zagaria A; Ventura M; Rocchi M; Panagopoulos I; Pannunzio A; Ottaviani E; Liso V; Specchia G
    Ann Hematol; 2004 Feb; 83(2):78-83. PubMed ID: 14551738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation.
    Kusec R; Laczika K; Knöbl P; Friedl J; Greinix H; Kahls P; Linkesch W; Schwarzinger I; Mitterbauer G; Purtscher B
    Leukemia; 1994 May; 8(5):735-9. PubMed ID: 7514242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.
    Licht JD
    Oncogene; 2001 Sep; 20(40):5660-79. PubMed ID: 11607817
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute myelocytic leukemia with ins(21;8)(q22;q13q22) presenting with AML1/MTG8 chimeric mRNA].
    Yamazaki E; Ogawa K; Harano H; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2000 Sep; 41(9):745-9. PubMed ID: 11070937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22.
    De Weer A; Speleman F; Cauwelier B; Van Roy N; Yigit N; Verhasselt B; De Moerloose B; Benoit Y; Noens L; Selleslag D; Lippert E; Struski S; Bastard C; De Paepe A; Vandenberghe P; Hagemeijer A; Dastugue N; Poppe B;
    Haematologica; 2008 Dec; 93(12):1903-7. PubMed ID: 18815193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An unusual three-way translocation t(21;8;1)(q22;q22;q32) in a case of acute myeloid leukemia (M2).
    Gmidène A; Sennana H; Frikha R; Elloumi M; Belaaj H; Saad A
    Ann Biol Clin (Paris); 2012; 70(2):213-6. PubMed ID: 22484534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a dual-color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia.
    Shearer BM; Sukov WR; Flynn HC; Knudson RA; Ketterling RP
    Am J Hematol; 2010 Aug; 85(8):569-74. PubMed ID: 20556821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T(1;21;8)(p34;q22;q22): a novel variant of t(8;21) in acute myeloblastic leukemia with maturation.
    Gmidène A; Frikha R; Sennana H; Elghezal H; Elloumi M; Saad A
    Med Oncol; 2011 Dec; 28 Suppl 1():S509-12. PubMed ID: 20949334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute myeloid leukemia with a RUNX1-RUNX1T1 t(1;21;8)(q21;q22;q22) novel variant: a case report and review of the literature.
    Kim H; Moon HW; Hur M; Yun YM; Lee MH
    Acta Haematol; 2011; 125(4):237-41. PubMed ID: 21325813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.